Table 1.
Comparison of basic charateristics among the control, total SGA, SGA with normal neonatal outcome and SGA with adverse neonatal outcome groups.
| Control (N = 461) | Total SGA (N = 47) | P1 | SGA with normal neonatal outcome (N = 30) | SGA with adverse neonatal outcome (N = 17) | P2 | P3 | |
| Age, years (mean ± SD) | 32.26 ± 4.07 | 31.4 ± 3.63 | .169 | 31.23 ± 3.67 | 32.71 ± 3.65 | .673 | .583 |
| Prepregnancy BMI, kg/m2 (mean ± SD) | 20.21 ± 2.69 | 18.79 ± 1.94 | <.001∗ | 18.77 ± 1.99 | 18.82 ± 1.91 | .924 | .036∗ |
| Primigravida (N, %) | 64.6 | 80.9 | <.001∗ | 75.8 | 82.1 | .312 | <.001∗ |
| Gestational weeks at delivery (mean ± SD) | 38.43 ± 1.49 | 38.36 ± 1.58 | .783 | 38.33 ± 1.64 | 38.41 ± 1.50 | .872 | .971 |
| Gender of baby (N, %) | |||||||
| Male | 48.7 | 42.6 | .421 | 40 | 47.1 | .558 | .65 |
| Female | 51.3 | 57.4 | 60 | 52.9 | |||
| Hemoglobin in early pregnancy, g/dl (mean ± SD) | 12 ± 1.15 | 12.21 ± 0.90 | .161 | 12.16 ± 0.81 | 12.28 ± 1.05 | .667 | .326 |
| Gestational weeks at 1st serum test | 11.45 ± 0.62 | 11.57 ± 0.61 | .265 | 11.61 ± 0.58 | 11.5 ± 0.67 | .623 | .781 |
| Gestational weeks at 2nd serum test | 15.8 ± 1.9 | 15.79 ± 2.0 | .885 | 15.72 ± 0.75 | 15.92 ± 0.49 | .316 | .498 |
| Gestational weeks at sFlt-1/PlGF I measurement | 26.1 ± 0.97 | 26.02 ± 0.95 | .591 | 25.9 ± 1.01 | 26.2 ± 0.83 | .25 | .578 |
| Gestational weeks at sFlt-1/PlGF II mesurement | 36.27 ± 1.18 | 36.22 ± 1.28 | .817 | 36.14 ± 1.356 | 36.38 ± 1.14 | .557 | .715 |
| BP in early pregnancy, mm Hg (mean ± SD) | |||||||
| Systolic | 112.39 ± 15.3 | 110.22 ± 17.2 | .202 | 110.97 ± 10.93 | 108.94 ± 9.23 | .525 | .206 |
| Diastolic | 66.15 ± 10.2 | 64.76 ± 10.3 | .253 | 65.52 ± 7.67 | 63.47 ± 3.95 | .314 | .016∗ |